Green Thumb has surged 17.5% in three months as regulatory progress, Q1 growth and buybacks lift sentiment, but competition and pricing pressure persist.
Green Thumb Industries Inc. (GTBIF) Q1 2026 Earnings Call Transcript
Green Thumb Industries Inc. (GTBIF) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
A recent licensing change could pave the way for higher profits.
At this time, the cannabis industry is growing at a fast pace. More companies are building and collaborating with other players in the industry to enhance their operations further. In the United States, cannabis regulations and operational guidelines in legal markets are still being updated and improved. Even though the development of a better industry has left the public sector with high levels of volatility.
Green Thumb Industries Inc. is upgraded to Buy, reflecting disciplined capital allocation, strong free cash flow, and a robust balance sheet amid industry distress. GTBIF's 2025 results show resilient FCF of $214M, manageable $245M debt, and opportunistic share buybacks, positioning it to consolidate as weaker peers falter. Management guides Q1 2026 revenue down mid-single digits due to pricing pressure and seasonality but maintains flexibility for organic growth, acquisitions, and buybacks.
Shares of Green Thumb GTBIF jump nearly 35% on a marijuana rescheduling order, but pricing pressure and weak comps cloud the stock's near-term outlook.
Green Thumb Industries stands to benefit significantly from cannabis rescheduling and the removal of 280E tax burdens. GTBIF trades at ~7x adjusted EBITDA, with potential for a 10x multiple if rescheduling and uplisting materialize. The company maintains strong cash flow, $226 million in cash, and has repurchased $107 million in shares despite tax headwinds.
Green Thumb Industries is rated a 'Buy,' driven by GAAP profitability, a strong balance sheet, and potential regulatory catalysts. GTBIF stands to benefit significantly if cannabis is rescheduled, potentially normalizing tax rates and boosting net income from $31 million to $106 million YTD. The company's conservative capital allocation, low leverage, and management discipline differentiate GTBIF amid sector volatility and persistent price compression.
Green Thumb Industries (GTBIF) is upgraded to strong buy, due to its attractive valuation, strong balance sheet, and relative underperformance, versus peers. GTBIF reported Q3 revenue above expectations and maintains positive tangible book value, with lower tax liabilities and net debt than competitors. Despite insider selling and sector risks, GTBIF's downside appears limited, and potential catalysts include 280E tax reform and adult-use legalization in key states.
Green Thumb Industries Inc. (GTBIF) came out with quarterly earnings of $0.04 per share, beating the Zacks Consensus Estimate of $0.03 per share. This compares to earnings of $0.04 per share a year ago.
Top cannabis companies are all awaiting the end of marijuana prohibtion. There has been a continuous battle to legalize cannabis to some degree federally. Many cannabis companies have made changes to prepare for what is to come. Most global regions that have legalized cannabis are working to meet the increased need for more cannabis products. This becomes possible through expanding and working on strategic partnerships to keep up as the cannabis industry evolves.